pharm ch 7

  1. Name 3 things SnF (stannous fl2) can be used for
    • 1. prevent caries
    • 2. avoid gingivitis
    • 3. reduce dentin hypersensitivity
  2. the major route of elimination of fl2 is released from the body through what?
    urine!
  3. what are the most common therapeutic products used by dental hygienists applied to?
    directly to the oral tissues
  4. who is the approval of the seal of acceptance?
    ADA (american dental association)
  5. t/f scientific basis must be used for recommending products
    true!
  6. nystatin is a drug that can produce:
    caries
  7. which drug might a patient be taking that can cause caries?
    nystatin (antibiotic to treat fungal infections)
  8. t/f professionally applied topical fluorides have been developed that add additional cariostatic benefits
    true!
  9. what is the newest topically applied fluoride by a professional that has positive anticaries benefits and a high safety profile?
    VARNISH
  10. what is the newest consumer product with strong evidence for effective caries prevention?
    xylitol
  11. a naturally occurring sweetener found in several plants with antibacterial and cariostatic properties is:
    xylitol
  12. what is proven to be the most efficacious antigingivitis agent, but early studies show an anticaries effect"
    CHX (chlorhexidine)
  13. t/f CHX varnish is available only in the US
    FALSE! it is not available in the US
  14. what is the primary goal of of oral health professionals?
    prevent dental caries and treat to initiate remineralization of enamel
  15. T/F anticaries efficacy of topical fl2 agents depends on their concentrations, frequency of application, and duration of application
    true
  16. in a fluoride, the _________ is the concern that poses a possible danger of poison when large amounts are swallowed
    concentration
  17. what is the most likely event that would occur if someone did not expectorate the topical fl2 agent and swallowed instead?
    nausea and vomiting
  18. what are the two current acceptable professionally applied topical fl2 agents?
    NaF and APF
  19. T/F the efficacy for caries prevention of NaF and APF is similar
    true
  20. why is the pt not allowed to eat or drink 30 minutes after fl2 application?
    ionic exchange continues for about 30 minutes
  21. professional fl2 applications in the enamel are not permanent because fl2 leaches from enamel over ___ to ___ weeks and returns to its preapplication levels
    5-8 weeks
  22. the annual 4-minute in-office applications of either NaF or APF from the dental office provides about a ____% reduction in caries in ________ teeth of children where water is not fluoridated
    • 26%
    • permanent
  23. which professionally applied fl2 is safest for a very young child?
    varnish
  24. T/F the majority of fl2 studies show the higher the fl2 concentration of topical agent, the worse the anticaries effect
    false, the BETTER the anticaries effect
  25. when should a fl2 agent of 5,000 ppm (gel) be recommended for a take home application? (what type of person)
    for someone with rampant caries, or increased risk for caries (e.g. from undergoing radiation therapy)
  26. list the order from most efficacious caries reduction to least:
    2% NaF
    1.23 APF
    5% NaF varnish
    • think concentrations! the higher the better.
    • #1. best = 5% NaF varnish
    • #2. 2% NaF
    • #3. 1.23% APF
  27. the decision to polish teeth is based on the presence of ________ _____ and for supragingival _______ removal
    • extrinsic stains
    • biofilm
  28. is it necessary to polish before a fl2 application?
    no, trials show whether or not polishing occurred the application efficacy was similar
  29. what does the neutral in neutral sodium fl2 represent?
    neutral pH of 7
  30. what anticaries agent has an agreeable taste, nonirritating to tissues and does not stain teeth or restorations?
    NaF
  31. NaF comes in a ___ or ___ and is relatively stable in a __% solution
    • gel or foam
    • 2%
Author
jackiedh
ID
68974
Card Set
pharm ch 7
Description
ch 7 topical agents
Updated